Deals Of The Week: J&J/Crucell, Merck/Beijing Genomics Institute …
Executive Summary
Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at http://invivoblog.blogspot.com.
You may also be interested in...
Four EU Biotechs Raise Extra Funds In Year-End Scramble
European biotechs tap investors for extra funding to support development plans.
Four EU Biotechs Raise Extra Funds In Year-End Scramble
European biotechs tap investors for extra funding to support development plans.
Turning To Not-For-Profits, AstraZeneca Bolsters Early Stage R&D
With patent expirations of major drugs looming, pharmaceutical companies are looking to trim expenses, especially in R&D, where expansive budgets have not generated returns – at least in terms of marketable products.